Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DATA-HD: High-Dose Teriparatide and Denosumab in Osteoporosis
NCT02176382Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Aug 2014
- Primary completion
- Feb 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of teriparatide in postmenopausal osteoporosis, sponsored by Massachusetts General Hospital. Started Aug 2014; status: completed.
02
Drugs
teriparatide
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT02176382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02176382.